e-Polimorfismoi: Development of an interactive e-health database aimed to identify potential interactions among drugs prescribed to CKD patients

e-Polimorfismoi: Development of an interactive e-health database aimed to identify potential interactions among drugs prescribed to CKD patients

Started At:
2018-09-25
Title:
e-Polimorfismoi: Development of an interactive e-health database aimed to identify potential interactions among drugs prescribed to CKD patients
Program:
Programme Epirus 2014-2020
Duration:
36 months
Summary:

The goal of the e-Polimorfismoi project is the design and development of an e-health platform to investigate drug interactions of multiple types (among drugs, between drugs and food, alcohols of other herbal products), for patients with chronic kidney disease (CKD), targeting the holistic treatment and personalized medication. The Department of Nephrology, University Hospital of Ioannina, will perform trials on 150 patients having CKD of various stages. On selected patients, specific genomic polymorphisms (pharmacogenetics tests) will be performed in order to widen the scope of the platform. The pilot clinical trials will be performed by the medical staff of the hospital in order to evaluate the effectiveness and usability of the platform.

 

Consortium:
  • Space Hellas (Coordinator)
  • UNIVEYE I.K.E.
  • University of Ioannina

Proud of our Partners

BT
Cisco
Dell Technologies
Microsoft
Oracle
Broadcom
Hyperscale
Airbus
APS
AXIS
BOSCH
Cellebrite
Check Point
Christie
Citrix
Crowd Strike
Epson
Forcepoint
Fortinet
FOX IT
Frequentis
Gamic
Genetec
HIKVISION
Honeywell
HP
HPE
HUAWEI
IBM
iCrypto
Indra
Legrand
Lenovo
LG
Microstep
Ivanti
NEC
NetApp
Novell
palo alto
Panduit
Peerless
Poly
PRIMX
RAD
Radware
Red Hat
Rittal
SΛMSUNG
Solarwinds
Splunk
Symantec
Synamedia
Thales
T Systems
Tufin
Vanguard
Veeam
Veritas
Web-IQ
Zetes
Zoom